Close
Nordic 9Nordic 9

Sundt AS (investor - Others)

Norway sundt-as.com
See something wrong or missing? Let us know
Offices:Oslo

Sundt AS is owned with 50 percent each by Helene Sundt AS and CGS Holding AS. Sundt as is a manegement comapany for these holding companies and is responsible for the day to day operation and management of the holding companies and their associated subsidiaries, as well as own subsidiaries.

Average round investment:19.46M USD
Average number per year:1.0
Distribution: 2024 (1)2021 (1)2020 (1)2018 (1)
Portfolio companies: Norway Arundo AnalyticsNorway OncoinventNorway Zelluna Immunotherapy As
Mostly invests in: Norway Norway (4) Energy (2)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Sundt AS mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Sundt AS

Name Criteria
Denmark Gro Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Energy, Competitive Intelligence, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Norway Acme Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Energy, Competitive Intelligence, Biotech
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Norway Ferd Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Energy, Competitive Intelligence, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
Norway Canica AS
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Energy, Competitive Intelligence, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
Poland Orlen VC
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Energy, Competitive Intelligence, Biotech
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States BoxGroup
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Energy, Competitive Intelligence, Biotech
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Riyadh Valley Company
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Energy, Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium François le Hodey
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Energy, Competitive Intelligence, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Jacques van Rijkervorsel
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Energy, Competitive Intelligence, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Jean Stéphenne
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Energy, Competitive Intelligence, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top